MedTrace Logo

Pharmacogenetics of b2-Agonists in Asthma.

NCT00708227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2018-02-22

Study results available
· View outcomes & findings →

Summary

This study will help to find out if having a certain genetic makeup influences how a person with asthma responds to salmeterol, one of the two drugs in Advair(R).

Conditions

Sponsors & Collaborators

  • University of Florida

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Nemours Children's Clinic

    lead OTHER

Principal Investigators

  • Kathryn Blake, Pharm.D. · Nemours Children's Clinic

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708227 on ClinicalTrials.gov